JUNS
JUPITER NEUROSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$2.82
−2.93%Margins
Gross margin
88.3%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
2513.7%
Return on equity
-247.4%
Return on assets
-709.4%
Return on invested capital
0.02x
Asset turnover
-$7.2M
Cash from operations
$1.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026